文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.

作者信息

Liu Hanzhang, Tao Tao

机构信息

Morphology Laboratory, Medical College of Nantong University, Nantong, Jiangsu, China.

Department of Clinical Medicine, Ningbo College of Health Science, Ningbo, Zhejiang, China.

出版信息

Front Oncol. 2022 Dec 20;12:1015850. doi: 10.3389/fonc.2022.1015850. eCollection 2022.


DOI:10.3389/fonc.2022.1015850
PMID:36605437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9808047/
Abstract

PURPOSE: Low-grade gliomas (LGG), which are malignant primary brain tumors, are more prevalent in young adults. Pyroptosis, an inflammatory form of programmed cell death, has been shown in recent years to be directly associated with tumor growth and tumor microenvironment (TME). However, the correlation between LGG and pyroptosis remained to be explored. In this research, we explored pyroptosis-related gene expression patterns and their prognostic significance based on transcriptome profiles and clinical data in LGG. METHODS: We identified 31 pyroptosis-related genes differentially expressed at the mRNA level between the data of LGG patients from TCGA and the data of normal brain tissues from GTEx. Univariate Cox regression analysis was used to screen 16 differentially expressed genes (DEGs) based on survival data. Next, the prognostic model was established using LASSO Cox regression, which divided LGG patients into high- and low- risk subgroups and showed an independent prognostic value for overall survival (OS) combined with clinical factors in the CGGA test cohort. Pyroptosis and immune cells were correlated through the CIBERSORT R package and the TIMER database. RESULTS: Based on the analyses of 523 LGG and 1152 normal tissues, nine significant differential genes were identified. The AUC remained at about 0.74 when combined with the risk score and clinical factors. Enrichment analyses revealed that DEGs were mainly enriched in cytokine-cytokine receptor interactions, immune response and chemokine signaling pathways. Immune cell enrichment analysis demonstrated that scores for most immune cell types differed significantly between the high-and low-risk groups, and further infiltrating analysis showed obvious differences between these two risk subgroups. CONCLUSION: Pyroptosis-related genes play a pivotal role in LGG and are associated with tumor immunity, which may be beneficial to the prognosis and immunotherapy of LGG.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/4009c587651c/fonc-12-1015850-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/aa32521f5cf9/fonc-12-1015850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/673d6961044e/fonc-12-1015850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/46a6a00cdb36/fonc-12-1015850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/4ae50a2ac029/fonc-12-1015850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/85e650779f02/fonc-12-1015850-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/af9e6ec5e8b1/fonc-12-1015850-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/4009c587651c/fonc-12-1015850-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/aa32521f5cf9/fonc-12-1015850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/673d6961044e/fonc-12-1015850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/46a6a00cdb36/fonc-12-1015850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/4ae50a2ac029/fonc-12-1015850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/85e650779f02/fonc-12-1015850-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/af9e6ec5e8b1/fonc-12-1015850-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfd9/9808047/4009c587651c/fonc-12-1015850-g007.jpg

相似文献

[1]
Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.

Front Oncol. 2022-12-20

[2]
Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.

J Mol Neurosci. 2023-8

[3]
TGF-β Score based on Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies.

Recent Pat Anticancer Drug Discov. 2024

[4]
A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma.

PeerJ. 2023

[5]
Screening TCGA database for prognostic genes in lower grade glioma microenvironment.

Ann Transl Med. 2020-3

[6]
A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.

BMC Cancer. 2021-12-7

[7]
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.

Front Immunol. 2022

[8]
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.

BMC Cancer. 2021-6-23

[9]
Pyroptosis-Related Genes as Markers for Identifying Prognosis and Microenvironment in Low-Grade Glioma.

J Healthc Eng. 2023

[10]
Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients.

J Oncol. 2022-5-19

引用本文的文献

[1]
An integrative analysis based on multiple cell death patterns identifies an immunosuppressive subtype and establishes a prognostic signature in lower-grade glioma.

Ann Med. 2024-12

[2]
Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them.

Front Oncol. 2024-8-9

本文引用的文献

[1]
A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.

Front Mol Biosci. 2022-8-17

[2]
Identification of a novel immune-related lncRNA signature to predict prognostic outcome and therapeutic efficacy of LGG.

J Integr Neurosci. 2022-3-22

[3]
NOD1 splenic activation confers ferroptosis protection and reduces macrophage recruitment under pro-atherogenic conditions.

Biomed Pharmacother. 2022-4

[4]
Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy.

Front Cell Dev Biol. 2021-11-23

[5]
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.

Front Genet. 2021-11-8

[6]
A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma.

Front Genet. 2021-10-13

[7]
Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma.

Front Pharmacol. 2021-10-12

[8]
Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma.

Bioengineered. 2021-12

[9]
A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma.

Front Oncol. 2021-8-17

[10]
Pyroptosis, metabolism, and tumor immune microenvironment.

Clin Transl Med. 2021-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索